0.021
0.00 (-8.70%)
| 前收盘价格 | 0.023 |
| 收盘价格 | 0.022 |
| 成交量 | 123,933 |
| 平均成交量 (3个月) | 206,411 |
| 市值 | 6,259,407 |
| 价格/销量 (P/S) | 0.700 |
| 股市价格/股市净资产 (P/B) | 0.590 |
| 52周波幅 | |
| 利润日期 | 31 Jul 2025 - 4 Aug 2025 |
| 营业毛利率 | -229.89% |
| 营业利益率 (TTM) | -287.38% |
| 稀释每股收益 (EPS TTM) | -0.040 |
| 季度收入增长率 (YOY) | 5.80% |
| 总债务/股东权益 (D/E MRQ) | 26.27% |
| 流动比率 (MRQ) | 2.99 |
| 营业现金流 (OCF TTM) | -10.28 M |
| 杠杆自由现金流 (LFCF TTM) | -7.86 M |
| 资产报酬率 (ROA TTM) | -44.24% |
| 股东权益报酬率 (ROE TTM) | -90.95% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (AU) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 混合的 | |
| 股票 | UNI BIOSEN CDI 1:1 [UBI] | - | - |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 0.0 |
| 平均 | -0.50 |
|
Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. It has one reportable segment: specialist biosensors company. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Growth |
| 内部持股比例 | 18.18% |
| 机构持股比例 | 50.99% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合